Insiders · GRTX

GRTX insider transactions

Galera Therapeutics Inc. (GRTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for GRTX

• 3d
  New insider Emerald Bioventures, Llc claimed ownership of 40,216,160 shares (SEC Form 3)

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 28d
  SEC Form 4 filed by Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 28d
  SEC Form 4 filed by Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 164d
  President and CEO Sorensen Mel sold $1,407 worth of shares (70,000 units at $0.02), decreasing direct ownership by 26% to 195,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 367d
  SEC Form 4 filed by Chief Accounting Officer Sussman Joel F.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 367d
  SEC Form 4 filed by President and CEO Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 490d
  Director Chang Nancy T bought $499,979 worth of shares (7,644,932 units at $0.07) (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 490d
  SEC Form 3 filed by new insider Chang Nancy T

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 490d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 490d
  SEC Form 3 filed by new insider Friedman Michael R.

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 625d
  President and CEO Sorensen Mel sold $4,825 worth of shares (67,015 units at $0.07), decreasing direct ownership by 20% to 265,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 721d
  New insider Soffer Rochel claimed ownership of 5,928,137 shares (SEC Form 3)

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 736d
  Schneid Yair bought $590,424 worth of shares (2,780,407 units at $0.21), increasing direct ownership by 35% to 10,823,610 units (SEC Form 4) (Amendment)

  4/A - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 765d
  Altamont Pharmaceutical Holdings, Llc sold $101,120 worth of shares (693,076 units at $0.15) (SEC Form 5)

  5 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 801d
  Schneid Yair bought $166,417 worth of shares (932,402 units at $0.18), increasing direct ownership by 13% to 8,043,203 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 842d
  New insider Schneid Yair claimed ownership of 7,110,801 shares (SEC Form 3)

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 906d
  New insider Altamont Pharmaceutical Holdings, Llc claimed ownership of 5,280,000 shares (SEC Form 3)

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1037d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1037d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1144d
  SEC Form 4 filed by Galera Therapeutics Inc.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1150d
  SEC Form 4: Degnan Chris bought $19,593 worth of shares (10,000 units at $1.96)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1150d
  SEC Form 4: Sorensen Mel bought $168,120 worth of shares (100,000 units at $1.68), increasing direct ownership by 43% to 332,044 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1262d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 10% to 108,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1332d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 11% to 98,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1343d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1343d
  SEC Form 3 filed by new insider Kennedy Eugene P.

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1387d
  SEC Form 4: Alleva Lawrence M gifted 4,000 shares, decreasing direct ownership by 63% to 2,325 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1402d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Holmlund Jon T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1599d
  SEC Form 4: West Linda bought $54,804 worth of shares (20,000 units at $2.74), increasing direct ownership by 50% to 60,000 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1599d
  SEC Form 4: Beardsley Robert A exercised 20,000 shares at a strike of $1.07, increasing direct ownership by 29% to 88,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 3 filed by new insider Bachleda Mark

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 3 filed by new insider Stacey Jennifer Evans

  3 - Galera Therapeutics, Inc. (0001563577) (Issuer)